| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $51.3M | -13.5% |
| SG&A Expense | $27.5M | +1.3% |
| Operating Income | -$78.8M | +8.9% |
| Income Tax | $0 | — |
| Net Income | -$69.7M | +15.5% |
| EPS (Basic) | -$1.27 | +32.4% |
| EPS (Diluted) | -$1.27 | +32.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $36.4M | -35.2% |
| Current Assets | $101.2M | -24.5% |
| Total Assets | $122.6M | -22.7% |
| Current Liabilities | $20.6M | +4.7% |
| Total Liabilities | $39.4M | -5.9% |
| Stockholders' Equity | $83.3M | -28.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$62.3M | +6.6% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $17.0M | +3.8% |
| Financing Cash Flow | $25.5M | -64.5% |
| Free Cash Flow | -$62.3M | +6.7% |